Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Taysha Gene Therapies, Inc. (TSHA)

Compare
1.2200
-0.0400
(-3.17%)
At close: April 4 at 4:00:02 PM EDT
1.2400
+0.02
+(1.64%)
After hours: April 4 at 7:35:33 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 2.02M
Earnings -18.79M

Q1'24

Q2'24

Q3'24

Q4'24

-20M
-10M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

5.00
6.55 Average
1.2200 Current
8.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2111
Avg. Estimate -0.1-0.09-0.38-0.41
Low Estimate -0.1-0.09-0.38-0.41
High Estimate -0.1-0.09-0.38-0.41
Year Ago EPS -0.1-0.09-0.36-0.38

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1010118
Avg. Estimate 1.48M1.77M5.89M2.38M
Low Estimate --------
High Estimate 3.8M5.6M15M8M
Year Ago Sales 3.41M1.11M8.33M5.89M
Sales Growth (year/est) -56.55%58.94%-29.32%-59.68%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -0.09-0.1-0.09-0.08
EPS Actual -0.1-0.09-0.07-0.07
Difference -00.010.020.01
Surprise % -3.20%14.80%20.89%15.39%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.1-0.09-0.38-0.41
7 Days Ago -0.10-0.260
30 Days Ago -0.10-0.260
60 Days Ago -0.10-0.260
90 Days Ago -0.10-0.260

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 11--1
Up Last 30 Days 11--1
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
TSHA -2.00%-5.63%-6.77%-7.89%
S&P 500 6.59%6.64%9.81%16.08%

Upgrades & Downgrades

Reiterates Needham: Buy to Buy 2/27/2025
Maintains Chardan Capital: Buy to Buy 2/26/2025
Reiterates Needham: Buy to Buy 1/6/2025
Maintains Canaccord Genuity: Buy to Buy 11/15/2024
Maintains Chardan Capital: Buy to Buy 11/14/2024
Reiterates Needham: Buy to Buy 11/14/2024

Related Tickers